In discounted cash flow (DCF) valuation techniques the value of the stock is estimated based upon present value of some measure of cash flow. Dividends are the cleanest and most straightforward measure of cash flow because these are clearly cash flows that go directly to the investor.
Paying users area
Try for free
Medtronic PLC pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Return on Equity (ROE) since 2005
- Current Ratio since 2005
The data is hidden behind: . Unhide it.
Get 1-month access^{} to Medtronic PLC for $19.99, or
get full access^{} to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Intrinsic Stock Value (Valuation Summary)
Year | Value | DPS_{t} or Terminal value (TV_{t}) | Calculation | Present value at |
---|---|---|---|---|
0 | DPS_{0}^{1} | |||
1 | DPS_{1} | = × (1 + ) | ||
2 | DPS_{2} | = × (1 + ) | ||
3 | DPS_{3} | = × (1 + ) | ||
4 | DPS_{4} | = × (1 + ) | ||
5 | DPS_{5} | = × (1 + ) | ||
5 | Terminal value (TV_{5}) | = × (1 + ) ÷ ( – ) | ||
Intrinsic value of Medtronic PLC common stock (per share) | ||||
Current share price |
Based on: 10-K (reporting date: 2022-04-29).
^{1} DPS_{0} = Sum of the last year dividends per share of Medtronic PLC common stock. See details »
Disclaimer!
Valuation is based on standard assumptions. There may exist specific factors relevant to stock value and omitted here. In such a case, the real stock value may differ significantly form the estimated. If you want to use the estimated intrinsic stock value in investment decision making process, do so at your own risk.
Required Rate of Return (r)
Assumptions | ||
Rate of return on LT Treasury Composite^{1} | R_{F} | |
Expected rate of return on market portfolio^{2} | E(R_{M}) | |
Systematic risk of Medtronic PLC common stock | β_{MDT} | |
Required rate of return on Medtronic PLC common stock^{3} | r_{MDT} |
^{1} Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).
^{2} See details »
^{3} r_{MDT} = R_{F} + β_{MDT} [E(R_{M}) – R_{F}]
= + [ – ]
=
Dividend Growth Rate (g)
Based on: 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28).
2022 Calculations
^{1} Retention rate = (Net income attributable to Medtronic – Dividends to shareholders) ÷ Net income attributable to Medtronic
= ( – ) ÷
=
^{2} Profit margin = 100 × Net income attributable to Medtronic ÷ Net sales
= 100 × ÷
=
^{3} Asset turnover = Net sales ÷ Total assets
= ÷
=
^{4} Financial leverage = Total assets ÷ Shareholders’ equity
= ÷
=
^{5} g = Retention rate × Profit margin × Asset turnover × Financial leverage
= × × ×
=
Dividend growth rate (g) implied by Gordon growth model
g = 100 × (P_{0} × r – D_{0}) ÷ (P_{0} + D_{0})
= 100 × ( × – ) ÷ ( + )
=
where:
P_{0} = current price of share of Medtronic PLC common stock
D_{0} = the last year dividends per share of Medtronic PLC common stock
r = required rate of return on Medtronic PLC common stock
Year | Value | g_{t} |
---|---|---|
1 | g_{1} | |
2 | g_{2} | |
3 | g_{3} | |
4 | g_{4} | |
5 and thereafter | g_{5} |
where:
g_{1} is implied by PRAT model
g_{5} is implied by Gordon growth model
g_{2}, g_{3} and g_{4} are calculated using linear interpoltion between g_{1} and g_{5}
Calculations
g_{2} = g_{1} + (g_{5} – g_{1}) × (2 – 1) ÷ (5 – 1)
= + ( – ) × (2 – 1) ÷ (5 – 1)
=
g_{3} = g_{1} + (g_{5} – g_{1}) × (3 – 1) ÷ (5 – 1)
= + ( – ) × (3 – 1) ÷ (5 – 1)
=
g_{4} = g_{1} + (g_{5} – g_{1}) × (4 – 1) ÷ (5 – 1)
= + ( – ) × (4 – 1) ÷ (5 – 1)
=